-
Je něco špatně v tomto záznamu ?
Long-term vagus nerve stimulation in children with focal epilepsy
M. Ryzí, M. Brázdil, Z. Novák, J. Chrastina, H. Ošlejšková, I. Rektor, R. Kuba,
Jazyk angličtina Země Dánsko
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
22994298
DOI
10.1111/ane.12009
Knihovny.cz E-zdroje
- MeSH
- antikonvulziva terapeutické užití MeSH
- dítě MeSH
- epilepsie parciální farmakoterapie terapie MeSH
- epilepsie tonicko-klonická farmakoterapie terapie MeSH
- hospitalizace statistika a číselné údaje MeSH
- incidence MeSH
- kašel etiologie MeSH
- lidé MeSH
- mladiství MeSH
- náhlé příhody epidemiologie MeSH
- následné studie MeSH
- poruchy polykání etiologie MeSH
- recidiva MeSH
- retrospektivní studie MeSH
- srdeční zástava etiologie MeSH
- vagová stimulace * škodlivé účinky MeSH
- výsledek terapie MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVES: The aim of the study was to evaluate the long-term efficacy and hospitalization rates in children with refractory focal epilepsy treated by vagus nerve stimulation. MATERIALS AND METHODS: We retrospectively analyzed 15 children with intractable focal epilepsy treated by vagus nerve stimulation (mean age of 14.6 ± 2.5 years at the time of implantation). We analyzed the treatment effectiveness at 1, 2, and 5 year follow-up visits. We counted the average number of urgent hospitalizations and number of days of urgent hospitalization per year for each patient before and after the VNS implantation. RESULTS: The mean seizure reduction was 42.5% at 1 year, 54.9% at 2 years, and 58.3% at 5 years. The number of responders was 7 (46.7%) at 1 year and 9 (60%) at both 2 and 5 years. The mean number of urgent hospitalizations per patient was 1.0 ± 0.6 per year preoperatively and 0.3 ± 0.5 per year post-operatively (P < 0.0001). The mean number of days of urgent hospitalization per patient was 9.3 ± 6.1 per year preoperatively and 1.3 ± 1.8 per year post-operatively ( < 0.0001). CONCLUSIONS: Vagus nerve stimulation is an effective method of treating children with refractory focal epilepsy. It leads to a substantial decrease in the number and duration of urgent hospitalizations.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14041001
- 003
- CZ-PrNML
- 005
- 20140108100004.0
- 007
- ta
- 008
- 140107s2013 dk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/ane.12009 $2 doi
- 035 __
- $a (PubMed)22994298
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a dk
- 100 1_
- $a Ryzí, M
- 245 10
- $a Long-term vagus nerve stimulation in children with focal epilepsy / $c M. Ryzí, M. Brázdil, Z. Novák, J. Chrastina, H. Ošlejšková, I. Rektor, R. Kuba,
- 520 9_
- $a OBJECTIVES: The aim of the study was to evaluate the long-term efficacy and hospitalization rates in children with refractory focal epilepsy treated by vagus nerve stimulation. MATERIALS AND METHODS: We retrospectively analyzed 15 children with intractable focal epilepsy treated by vagus nerve stimulation (mean age of 14.6 ± 2.5 years at the time of implantation). We analyzed the treatment effectiveness at 1, 2, and 5 year follow-up visits. We counted the average number of urgent hospitalizations and number of days of urgent hospitalization per year for each patient before and after the VNS implantation. RESULTS: The mean seizure reduction was 42.5% at 1 year, 54.9% at 2 years, and 58.3% at 5 years. The number of responders was 7 (46.7%) at 1 year and 9 (60%) at both 2 and 5 years. The mean number of urgent hospitalizations per patient was 1.0 ± 0.6 per year preoperatively and 0.3 ± 0.5 per year post-operatively (P < 0.0001). The mean number of days of urgent hospitalization per patient was 9.3 ± 6.1 per year preoperatively and 1.3 ± 1.8 per year post-operatively ( < 0.0001). CONCLUSIONS: Vagus nerve stimulation is an effective method of treating children with refractory focal epilepsy. It leads to a substantial decrease in the number and duration of urgent hospitalizations.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a antikonvulziva $x terapeutické užití $7 D000927
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a kašel $x etiologie $7 D003371
- 650 _2
- $a poruchy polykání $x etiologie $7 D003680
- 650 _2
- $a náhlé příhody $x epidemiologie $7 D004630
- 650 _2
- $a epilepsie parciální $x farmakoterapie $x terapie $7 D004828
- 650 _2
- $a epilepsie tonicko-klonická $x farmakoterapie $x terapie $7 D004830
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a srdeční zástava $x etiologie $7 D006323
- 650 _2
- $a hospitalizace $x statistika a číselné údaje $7 D006760
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a výsledek terapie $7 D016896
- 650 12
- $a vagová stimulace $x škodlivé účinky $7 D055536
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Brázdil, M $u -
- 700 1_
- $a Novák, Z $u -
- 700 1_
- $a Chrastina, J $u -
- 700 1_
- $a Ošlejšková, H $u -
- 700 1_
- $a Rektor, I $u -
- 700 1_
- $a Kuba, R $u -
- 773 0_
- $w MED00009024 $t Acta neurologica Scandinavica $x 1600-0404 $g Roč. 127, č. 5 (2013), s. 316-22
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22994298 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140107 $b ABA008
- 991 __
- $a 20140108100705 $b ABA008
- 999 __
- $a ok $b bmc $g 1005397 $s 839513
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 127 $c 5 $d 316-22 $i 1600-0404 $m Acta neurologica Scandinavica $n Acta Neurol Scand $x MED00009024
- LZP __
- $a Pubmed-20140107